Jump to content

Wikipedia:Elsevier ScienceDirect

From Wikipedia, the free encyclopedia
The Wikipedia Library

Elsevier ScienceDirect

Elsevier is an academic publishing company that publishes medical and scientific literature, as a "provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions—among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey—and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles."

Elsevier has donated ScienceDirect access. ScienceDirect is their full-text database with "almost a quarter of the world's peer-reviewed scientific content". The database includes over 2,500 journals, 900 serials and 26,000 book titles. Journals include, among others, The Lancet, Cell, Current Biology, Biomaterials, Biological Psychiatry, Social Science & Medicine, Current Biology, Cognition, and Behavioural Brain Research. For a full list of journals included in Elsevier's ScienceDirect, see their website.

Wikipedia Library access

Elsevier is offering free accounts to its published content online on ScienceDirect to help write Wikipedia content in a great variety of topics, from health to astronomy. To facilitate verification in more specific areas of the encyclopedia, the accounts have been split across three access collections:

Wikipedia editors may apply for one of these ScienceDirect access collections according to their area of specialty; their account will be valid for a period of one year.

Userbox

Add {{Wikipedia:Elsevier ScienceDirect/Userbox}} to your userboxes! This helps us share our project with other experienced users.

ScienceDirectThis user has access to Elsevier's ScienceDirect through The Wikipedia Library.

Example citation

<ref> {{cite journal |title=Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator |author=Ishida, Seiko |author2=McCormick, Frank |author3=Smith-McCune, Karen |author4=Hanahan, Douglas |doi=10.1016/j.ccr.2010.04.011 |date=15 June 2010|volume=17|issue= 6|pages= 574–583 | journal =Cancer Cell}} {{Subscription or libraries|sentence|via=[[ScienceDirect]]}}</ref>
  • Ishida, Seiko; McCormick, Frank; Smith-McCune, Karen; Hanahan, Douglas (15 June 2010). "Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator". Cancer Cell. 17 (6): 574–583. doi:10.1016/j.ccr.2010.04.011.  – via ScienceDirect (Subscription may be required or content may be available in libraries.)